Notice of Effectiveness

Cytosorbents Corp Filed 2018-08-07 Acc 9999999995-18-002029

Documents 1

2021-07-27 EFFECT Notice of Effectiveness
2018-08-07 EFFECT Notice of Effectiveness
2018-08-07 4 Chief Financial Officer sold 10,000 shares at an average $12.54 ($125,364)
2018-08-06 4 Chief Operating Officer sold 10,435 shares at an average $13.06 ($136,263)
2018-08-03 CORRESP Correspondence Between Filers and SEC Staff
2018-08-03 S-3/A Registration Statement
2015-10-20 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…